Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma (Q39643717)

13 September 2017

title

Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma (English)

1 reference

13 September 2017

1 reference

Minoru Fujimoto

3

0 references

Satoshi Serada

object named as

Satoshi Serada

2

0 references

Tetsuji Naka

object named as

Tetsuji Naka

13

0 references

Shintaro Nomura

4

object named as

Shintaro Nomura

1 reference

13 September 2017

9

Barry Ripley

1 reference

13 September 2017

6

Chun Man Lee

1 reference

13 September 2017

1

Kota Iwahori

1 reference

13 September 2017

10

Meinoshin Okumura

1 reference

13 September 2017

11

Ichiro Kawase

1 reference

13 September 2017

Tadashi Osaki

5

1 reference

13 September 2017

Hiroyuki Mizuguchi

7

1 reference

13 September 2017

Tsuyoshi Takahashi

8

1 reference

13 September 2017

Tadamitsu Kishimoto

12

1 reference

13 September 2017

language of work or name

English

0 references

publication date

2 December 2010

1 reference

International Journal of Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

129

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

1005-1017

1 reference

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

13 September 2017

cites work

1 reference

The Mesothelioma epidemic in Western Europe: an update

21 January 2018

1 reference

Malignant mesothelioma in Australia, 1945-2002.

21 January 2018

1 reference

Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40

21 January 2018

1 reference

Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model.

21 January 2018

1 reference

The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma

21 January 2018

1 reference

Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway

21 January 2018

1 reference

Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas

21 January 2018

1 reference

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

Structure and function of a new STAT-induced STAT inhibitor

21 January 2018

1 reference

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

Controlling cytokine signaling by constitutive inhibitors

21 January 2018

1 reference

Negative regulation of cytokine and TLR signalings by SOCS and others

21 January 2018

1 reference

SOCS proteins, cytokine signalling and immune regulation

21 January 2018

1 reference

Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130

21 January 2018

1 reference

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

21 January 2018

1 reference

Stat proteins and oncogenesis

21 January 2018

1 reference

Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells

21 January 2018

1 reference

Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.

21 January 2018

1 reference

SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130

21 January 2018

1 reference

Negative regulation of FAK signaling by SOCS proteins

21 January 2018

1 reference

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome

21 January 2018

1 reference

Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells

21 January 2018

1 reference

Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif

21 January 2018

1 reference

LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells

21 January 2018

1 reference

WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation

21 January 2018

1 reference

The genetics of the p53 pathway, apoptosis and cancer therapy

21 January 2018

1 reference

Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin

21 January 2018

1 reference

Mutation of phosphoserine 389 affects p53 function in vivo

21 January 2018

1 reference

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

21 January 2018

1 reference

ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation

21 January 2018

1 reference

p21 in cancer: intricate networks and multiple activities

21 January 2018

1 reference

SOCS1 links cytokine signaling to p53 and senescence

21 January 2018

1 reference

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

21 January 2018

1 reference

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25716

1 reference

13 September 2017

1 reference